Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence

Clinical trial NCT01874951 · COMPLETED

Trial details

NCT number: NCT01874951
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder Depression, Unipolar Recurrence Relapse

Start date: 2013-06-01
Primary completion: 2015-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.